Nektar Therapeutics | NKTR - EPS Earnings Per Share


Nektar Therapeutics reported $-0.18 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
ALKERMES USD 0.29 0.2 Dec/2025
Alterity Therapeutics Limited AUD 0 0 Dec/2023
Amgen USD 5.29 0.35 Dec/2025
Baxter International USD 0.44 0.25 Dec/2025
BioCryst Pharmaceuticals USD -0.13 0.06 Dec/2024
Biogen USD 1.99 2.82 Dec/2025
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Cara Therapeutics USD -5.04 3.24 Dec/2024
Cipla INR 15.2 1.52 Dec/2025
Dr.Reddys Laboratories INR 14.52 2.98 Dec/2025
Eisai JPY 60.94 24.92 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Exelixis USD 0.97 0.19 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.26 0.29 Dec/2025
Grifols EUR 0.29 0.03 Mar/2026
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Incyte USD 1.8 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
Ironwood Pharmaceuticals USD -0.01 0.25 Dec/2025
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 0.27 0.84 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Nektar Therapeutics USD -0.18 0.07 Sep/2024
Neurocrine Biosciences USD 1.88 0.29 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
Pfizer USD 0.66 0.21 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Takeda JPY 65.74 73.57 Dec/2025
Teva Pharmaceutical Industries USD 2.98 0.43 Dec/2025
Xencor USD -0.09 0.01 Dec/2025